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Objective: Vagus nerve stimulation (VNS) has recently been used in
neurorehabilitation and the recovery of consciousness based on its
effects on cortical plasticity. The aim of this study was to examine the
therapeutic effects of VNS on patients with a minimally conscious state
(MCS).
Methods: All patients included in the study were assessed more than 5
months after injury and were receiving regular rehabilitation at our
hospital from August 2018 to October 2019. Ten patients diagnosed with
MCS by Coma Recovery Scale‐Revised (CRS‐R) test who underwent
VNS surgery were enrolled. The scores on CRS‐R evaluation at baseline
(before VNS implantation) and 1, 3, and 6 months after VNS treatment
were recorded. The stimulation parameters were chosen according to a
previous study. All clinical rehabilitation protocols remained unchanged
during the study. Furthermore, safety was assessed by analyzing
treatment‐emergent adverse events (TEAEs).
Results: No significant improvement in the total CRS‐R scores at the end
of the 1‐month follow‐up was observed (p > 0.05). After 3 months of
stimulation, a significant difference (p = 0.0078) was observed in the total
CRS‐R scores compared with the baseline. After 6 months of VNS
treatment, CRS‐R assessments showed a continuous significant
improvement (p = 0.0039); one patient emerged from the MCS and
recovered functional communication and object use. Interestingly, one
item of CRS‐R scores on visual domain was sensitive to VNS treatment
(p = 0.0039). Furthermore, no serious adverse event occurred throughout
the study.
Conclusion: This exploratory study provides preliminary evidence
suggesting that VNS is a safe and effective tool for consciousness
recovery in patients with MCS.
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Introduction

Disorders of consciousness (DOC) are one of
many neurological disorders caused by severe
brain injury, including coma, unresponsive
wakefulness syndrome (UWS, or vegetative
state), and minimally conscious state (MCS) [1,
2]. MCS is characterized by severe dysfunctions
in consciousness, and unlike vegetative state
(VS), patients with MCS have a clear and
repeated awareness of themselves or their
surrounding environment [3]. Once patients
recover functional communication or object use,
they emerge from the MCS [4]. Due to the
impairments of various functions in the brain,
such as UWS, MCS can be temporary or
permanent. Therefore, it is very difficult to
distinguish it from the VS clinically, and the
probability of misdiagnosis is very high [5].
Fortunately, modern neuroimaging and elec‐
trophysiological studies have found that MCS
and VS are significantly different with regard to
residual brain function, sensitivity to stimula‐
tions, and medical prognosis [2, 4, 6]. Recent
clinical evidence demonstrates that unlike in
VS/UWS, disrupted cortical networks contribute
overtly to the symptoms expressed in MCS [7–9].
In other terms, compared with VS/UWS, MCS
can be reinterpreted as a cortically mediated state
(CMS) and is more likely to evolve to the
recovery of consciousness [10].
However, no curative strategy for patients
with DOC has been established to date. The
main stream of therapeutic options performed
in these patients has focused on accelerating the
clinical recovery through pharmacological
interventions [11–13], sensory stimulation [14–16],
or neuromodulatory brain stimulation [17–21].
For the treatment of MCS, many traditional
methods result in poor outcomes. In recent years,
novel neuromodulatory treatments, such as deep
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brain stimulation (DBS), spinal cord stimulation
(SCS), transcranial magnetic stimulation, and
VNS [22–25], have been widely applied in
restoring consciousness and cognitive function.
But these emerging methods are still under
investigation in order to verify their efficiency
and safety. VNS has been proven as a promising
neuromodulatory
electroceutical
in
the
treatment of medically intractable epilepsy [26]
and drug‐resistant depression [27] and holds
potential for the management of a wide range of
neuropsychiatric disorders by reversing the
pathological brain plasticity [28, 29]. The
implications of the connectomics and the
introduction of large‐scale remodeling of brain
networks has helped elucidate the underlying
neurophysiology of VNS [30]. A lot of evidence
has been reported that VNS paired with sensory,
motor, or cognitive training can generate highly
specific, long‐lasting, and therapeutic neural
plasticity that results in relevant cognitive and
behavioral changes [29, 31]. The proposed
mechanisms involve a range of influences on
different levels in the nervous system, including
the alterations of neurotransmitters, synaptic
connections, neuro‐glial communications, anti‐
inflammatory effects, as well as neurogenesis [29,
30, 32, 33]. VNS can influence important
components of the limbic system via the
anatomical projection pathways, such as the
amygdala, hippocampus, thalamus, hypothalamus,
and neocortex via recruiting monoaminergic
signalings, which include glutamate (Glu),
serotonin (5‐HT), dopamine (DA), and
norepinephrine (NE) [34]. VNS can also directly
lead to the rapid and transient enhancement of
the thalamic information transmission [35] and
the activation of brain regions which covers
more than 76% of the brain volume [36]. Thus,
VNS‐activated brain regions were involved in
the dominant corticothalamic circuits in which
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the disconnections in the cortico–cortical and
thalamo–cortical pathways mediated the neural
mechanisms of the impaired consciousness [4,
21]. Such finding implies that VNS could be an
effective tool for patients with MCS. It not only
helps in the emergence from MCS but also in
boosting the cognitive and locomotive rehabilita‐
tion, because most of these patients still have
severe cognitive and motor impairments [37].
Vagus nerve stimulation (VNS) has recently
been applied in neurorehabilitation based on its
effects on reversing pathological cortical circuits
by targeting the vagus afferent network [32, 33,
38, 39]. Clinical evidences suggest that VNS
reduces daytime sleepiness, promotes vigilance
in refractory epilepsy, and maintains the
awakening state of epilepsy patients with
impaired consciousness [40–42]. Three studies
that used VNS have shown promising results in
increasing the consciousness level in patients
with DOC after severe traumatic brain injury [21,
43, 44]. Moreover, data from animal studies also
suggest that VNS may have beneficial effects on
the recovery of consciousness and cognitive
function following experimental TBI (traumatic
brain injury) [45]. Such evidences further
suggest the activation of the task‐related brain
region and regulation of neuroplasticity in the
cortex could be facilitated by VNS in patients
Table 1

with MCS. However, the therapeutic effect of
VNS on patients with MCS has not been
systematically investigated.
In this study, we hypothesized that VNS
treatment paired with regular neurorehabilita‐
tion would improve the recovery of consciousness
in patients with MCS. Ten patients diagnosed
with MCS using the Coma Recovery Scale‐
Revised (CRS‐R) test who underwent VNS
surgery were enrolled to determine the
therapeutic effects of VNS on DOC.

2
2.1

Materials and methods
Participants

Ten patients (5 males and 5 females, mean age
43.90 ± 15.79 years) with MCS who underwent
VNS implantation in our hospital from August
2018 to October 2019 were enrolled. The time
since injury was on an average of 7.16 ± 2.12
months and ranged from 5 months to 11.5
months (Table 1). We enrolled patients who met
the following inclusion criteria: (1) regular and
systematic neurorehabilitation for more than 5
months after brain injury, with age ≥ 18 years
old; (2) at least one neurological examination
and consistent with MCS defined by the CRS‐R

Clinical information of MCS patients.

Case

Sex

Age (years)

Causes

Course (months)

1

Male

24

Traumatic brain injury

6

2

Female

61

Traumatic brain injury

10

3

Female

66

Cerebral infarction, hemorrhage after thrombolysis

5

4

Male

19

Traumatic brain injury

6

5

Female

55

Cerebral hemorrhage

7

6

Female

47

Traumatic brain injury

6.5

7

Male

51

Cerebral hemorrhage

8

8

Female

39

Cerebral hemorrhage

5

9

Male

48

Cerebral hemorrhage

6.6

10

Male

29

Hypoxic–ischemic encephalopathy

11.5
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test; and (3) informed written consent for the
patients’ participation of the study given by their
legal surrogates. The exclusion criteria included
the following: (1) patients in a vegetative state;
(2) with an injury course less than 5 months; (3)
aged < 18 years old; (4) patients’ legal surrogates
disagree with the VNS treatment; (5) patients
who were in poor condition (dysfunction of
important organs or obvious infections) and
cannot support the operation. The Ethics
Committee of the Jiangbin Hospital approved
the whole protocol and procedure in this study.

amplitude was increased by 0.2–0.3 mA every

2.2

The CRS‐R test was used to assess the clinical

VNS implantation

Before the VNS implantation, all the patients
were assigned to undertake the following
preoperative examinations: (1) routine preoperative
examination (chest radiograph, electrocardiogram,
and laboratory test) to understand the function
of each important organ and surgery tolerance;
(2) preoperative skull computed tomography
(CT) and/or magnetic resonance imaging (MRI)
examination to understand the situation of
intracranial injury; and (3) electroencephalogram
(EEG).
Following the clinical screening, the patients
were formally included in the study to receive
the VNS System (G112, PINS Medical, Ltd.,
Beijing, China) implantation performed as VNS
for medically refractory epilepsy.
2.3

Adjustment of VNS parameters

1–2 weeks until the maximal current of 1.5 mA
was

reached.

Afterwards,

the

parameter

adjustment was based on the patient’s tolerance
and clinical conditions, but the maximum
current is less than 3.5 mA (Suppl. 1). When the
VNS was

reaching a satisfactory

efficacy

without obvious adverse events, the stimulation
parameters were kept unvaried throughout the
following months.
2.4

Behavioral assessment

state of the patient along with the whole
protocol of the VNS treatment. During the
baseline and VNS sessions (1 month, 3 months,
and 6 months after implantation), a CRS‐R
evaluation was performed by expert clinicians.
Emergence from a minimally conscious state:
when

patients

were

able

to

functionally

communicate or adequately use two different
objects, it was considered an emergence from
the MCS. Significant improvement: at least 4
points in the total CRS‐R scores were increased.
VNS‐responsive patients: CRS‐R score increased
by ≥ 2 points. Unresponsive patients: the total
CRS‐R scores increased by ≤ 1. Safety was
primarily assessed in the analysis of the
treatment‐emergent adverse events (TEAEs).
2.5

Statistical analysis

The device was switched on about 2–4 weeks
after the implantation at an initial current

Descriptive analysis was conducted to summarize

0.1–0.3 mA with a pulse frequency of 20–30 Hz

the patient characteristics. A Wilcoxon matched‐

and a pulse duration of 250 or 500 μs. The

pairs signed rank test was used for one sample

protocol followed the standard stimulation

comparison

cycles, previously used for medically refractory

variables. A p‐value < 0.05 was considered a

epilepsy treatment, consisting of 30 seconds of

statistically significant difference. All statistical

stimulation interleaved by 5 minutes of rest.

analyses were performed in GraphPad Prism

During the first month and a half, the current

v8.0 (GraphPad; LaJolla, CA).

of

the

abnormally

distributed

Journal of Neurorestoratology

164

3

Results

10 patients (5 males and 5 females, mean age
43.90 ± 15.79 years) with MCS who underwent
VNS implantation were enrolled in this study.
The time since injury was on an average of 7.16
± 2.12 months and ranged from 5 months to 11.5
months. The causes of MCS included four cases
of traumatic brain injury, five cases of cerebral
hemorrhage, and one case of ischemic hypoxic
encephalopathy (Table 1). All the patients
completed the 6‐month follow‐up. No severe
adverse events related to the VNS implantation
or programming were recorded during the
therapeutic protocol.
Moreover, no significant improvement was
observed in the total CRS‐R scores at the end of
the 1‐month follow‐up versus baseline (p > 0.05)
(Table 2 and 3). After 3 months of stimulation, a
significant difference in the total CRS‐R scores
compared with that at baseline (p = 0.0078), 3/10
(30.0%) showed a significant improvement; 2/10
(20.0%) were VNS‐responders, and 5/10 cases
(50.0%) were unresponsive to the VNS treatment.
Specifically, one CRS‐R subscale on the visual
function was more sensitive to VNS (p = 0.0156)
(Table 4). Surprisingly, CRS‐R assessments
showed a continuous significant improvement
Table 3

(p = 0.0039) after 6 months of stimulation.
Similarly, visual function significantly improved
compared with that at baseline (p = 0.0078). 1/10
(10.0%) has emerged from the minimally
conscious state and recovered functional
communication and object use. 2/10 (20.0%)
showed a significant improvement, 3 /10 (30.0%)
were responsive, and 5/10 (50.0%) were
unresponsive to VNS. However, no difference
was observed in the total and subscale CRS‐R
assessments in a comparison between the 6‐ and
3‐month follow‐ups (p > 0.05) (Table 2 and 4).
Table 2 The total CRS‐R scores of MCS patients at baseline
and 1 month, 3 months , 6 months after VNS.
Postoperation
Case

Baseline
1 month

3 months

6 months

1

10

11

12

12

2

12

12

12

13

3

11

11

11

11

4

10

11

11

11

5

12

12

18

23

6

12

12

14

14

7

12

12

16

18

8

12

12

13

13

9

11

12

16

16

10

10

10

11

11

Statistical analysis (p‐value) of behavioral assessment by CRS‐R test.
1M vs. baseline

3M vs. baseline

6M vs. baseline

1M vs.3M

1M vs. 6M

3M vs. 6M

Total CRS‐R score

> 0.05

0.0078

0.0039

0.0156

0.0078

> 0.05

Auditory function

/

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

Visual function

> 0.05

0.0156

0.0078

0.0313

0.0156

> 0.05

Motor function

/

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

/

/

> 0.05

/

/

/

> 0.05

> 0.05

> 0.05

> 0.05

> 0.05

/

Oromotor/verbal function
Communication
Arousal

Neither of the 10 patients had complications such as nerve damage, arrhythmia, or infection of the surgical mouth.
/, no difference and cannot be analyzed. M, month(s).
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The specific CRS‐R subscales of each patient during follow‐up.

Auditory function
scale
Case
Base‐
1M 3M 6M
line
1

165

2

2

2

2

Visual function
Motor function
Oromotor/verbal Communication
Arousal
scale
scale
function scale
scale
scale
Base‐
Base‐
Base‐
Base‐
Base‐
1M 3M 6M
1M 3M 6M
1M 3M 6M
1M 3M 6M
1M 3M 6M
line
line
line
line
line
1

2

2

2

3

3

3

3

1

1

2

2

1

1

1

1

2

2

2

2

2

2

2

2

2

2

2

2

3

3

3

3

3

2

2

2

2

1

1

1

1

2

2

2

2

3

2

2

2

2

2

2

2

2

3

3

3

3

1

1

1

1

1

1

1

1

2

2

2

2

4

2

2

2

2

2

2

2

2

3

3

3

3

1

1

1

1

1

1

1

1

1

2

2

2

5

2

2

3

4

3

3

4

5

3

3

5

6

1

1

2

3

1

1

1

2

2

2

3

3

6

2

2

3

3

2

2

3

3

3

3

3

3

2

2

2

2

1

1

1

1

2

2

2

2

7

2

2

3

3

2

2

4

4

3

3

3

5

2

2

2

2

1

1

1

1

2

2

3

3

8

2

2

2

2

2

2

3

3

3

3

3

3

2

2

2

2

1

1

1

1

2

2

2

2

9

2

2

3

3

2

2

3

3

3

3

4

4

1

2

2

2

1

1

1

1

2

2

3

3

10

2

2

2

2

2

2

3

3

3

3

3

3

1

1

1

1

1

1

1

1

1

1

1

1

M, month(s).

4

Discussion

To the best of our knowledge, this is the largest
single‐center prospective study assessing the
overall efficacy, safety, and tolerability of the
surgically implanted VNS in MCS patients so far.
In this study, the CRS‐R test was used to
evaluate the clinical states of 10 patients with
MCS treated with VNS. No significant
improvement was observed in total CRS‐R
scores at the end of the 1‐month follow‐up. The
outcomes of the VNS treatment need time to
emerge as well‐known, just like its cumulative
benefits observed in patients with epilepsy or
depression who underwent the VNS implantation.
The nature of experience‐dependent neural
plasticity explains the need for intensive and
repetitive stimulation over time for a therapeutic
procedure of rehabilitation in humans with
brain damage [28]. After 3 months of stimula‐
tion, a significant difference was observed in the
total CRS‐R scores compared with that at
baseline: 3/10 (30.0%) showed a significant
improvement at 3 months after VNS treatment,
and 2/10 (20.0%) were responsive. After 6
months of VNS treatment, CRS‐R assessments

showed a continuous significant improvement: 1
patient has emerged from the MCS, 2/10 (20.0%)
showed significant improvement, and 2/10
(20.0%) were responsive. Six months was proven
enough to observe the physical and neurological
changes based on the CRS‐R results after the
VNS treatment [21]. Interestingly, one CRS‐R
subscale item, visual item, was sensitive to the
VNS treatment. Moreover, this result is
consistent with the previous study in which
scores on the CRS‐R test improved, mostly in the
visual domain, as stimulation increased during
the VNS treatment [21]. Animal studies also
revealed that VNS had transitory effects on the
neural activity of the primary visual pathway
structures and interferes with the development
and establishment of visual habituation [46].
The pattern of changes described here could be
explained in the literature regarding the
VNS‐directed auditory map plasticity mediated
by neurotransmitters to treat tinnitus [47] and
the enhancement of motor cortex plasticity in
stroke recovery [32, 33]. The above results show
that VNS works slowly, but continuously, in
patients with MCS. This phenomenon may be
related to the increasing large‐scale functional
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connectivity and reversing pathological brain
plasticity because of the long‐lasting effects of
VNS, and persistent clinical changes may
require a continuous application of the
neurophysiological technique to be detected.
The curative effects of tVNS (transcutaneous
vagus nerve stimulation) have been preliminary
verified in patients with a persistent impairment
of consciousness [25, 44]. However, it is difficult
to directly compare the therapeutic effect
between tVNS and VNS, because of the different
stimulation methods, efficiency, and duration.
Meanwhile, the application of tVNS is still
under initiatory investigation and needs more
controlled studies with large samples to assess
its long‐term effects and safety, but the
advantage of tVNS is that patients with DOC
can receive therapy in an noninvasive manner
and at a relative low cost.
It has been agreed that DOC may involve
impairments in the long‐range cortico‐cortical
and thalamo‐cortical circuits, and the neural
signature of spontaneous recovery is linked to
increased thalamo‐cortical activity and improved
fronto‐parietal functional connectivity [48]. It is
known that vagal fibers first project to the
nucleus tractus solitarious (NTS), which serves
as a major relay center of vagal afferent
pathways and subsequently travels to other
brainstem nuclei important in modulating the
activity of subcortical and cortical circuitry [30].
Therefore, more
neurophysiological and
neuroimaging data are required to clinically
evaluate the alterations of preserved brain
connectivity and cortical plastic properties in
patients with MCS after VNS. At the same time,
this is the most common deficiency of our
research, and we will improve the neurophy‐
siological and imaging tools to make a
comprehensive study. In addition, VNS may
protect the internal organs of the body by

triggering inflammation reflex and enhancing
metabolic activity [31]. Thus, more physiological
evaluation, such as heart rate, respiration
function, body motility, and inflammation level,
should be considered in future studies. Our
results suggested that the use of VNS was
feasible and safe in patients with DOC and that
it may improve behavioral responses when
applied to patients with MCS. It should be
emphasized that VNS may continuously boost
cognitive and locomotive rehabilitation even
after emergence from MCS, considering that
VNS paired with a specific stimulus can reverse
the pathological neuronal circuits [32, 38, 39],
but this requires a longer follow‐up period and
more systematic research to confirm.
Although some improvements were observed
in our study, these results should be interpreted
with caution considering the lack of a control
group, small sample size, and inadequate
follow‐up time.

5

Conclusion

This exploratory study provides a preliminary
evidence suggesting that VNS could be a safe
and effective tool to facilitate consciousness
recovery in patients with MCS. It appears that
the recovery of visual perception may be more
likely to benefit from VNS treatment. Longer
treatment periods and more controlled clinical
trials are required to verify the effect of VNS in
patients with DOC, especially considering that
this technique seems to be safe and well‐
tolerated in this population.

Conflict of interests
All contributing authors reported no conflicts of
interests in this work.

Journal of Neurorestoratology

Journal of Neurorestoratology

References
[1] Giacino JT, Fins JJ, Laureys S, et al. Disorders of
consciousness after acquired brain injury: the state of
the science. Nat Rev Neurol. 2014, 10(2): 99–114.
[2] Giacino JT, Katz DI, Schiff ND, et al.
Comprehensive systematic review update summary:
disorders of consciousness: report of the guideline
development, dissemination, and implementation
subcommittee of the American academy of
neurology; the American congress of rehabilitation
medicine; and the national institute on disability,
independent living, and rehabilitation research.
Neurology. 2018, 91(10): 461–470.
[3] Hodelín-Tablada R. Minimally conscious state:
evolution of concept, diagnosis and treatment.
MEDICC Rev. 2016, 18(4): 43–46.
[4] Thibaut A, Schiff N, Giacino J, et al. Therapeutic
interventions in patients with prolonged disorders of
consciousness. Lancet Neurol. 2019, 18(6): 600–614.
[5] Schnakers C, Vanhaudenhuyse A, Giacino J, et al.
Diagnostic accuracy of the vegetative and minimally
conscious state: Clinical consensus versus standardized
neurobehavioral assessment. BMC Neurol. 2009, 9(1):
1–5.
[6] Rodriguez Moreno D, Schiff ND, Giacino J, et al. A
network approach to assessing cognition in disorders
of consciousness. Neurology. 2010, 75(21):
1871–1878.
[7] Fernández-Espejo D, Soddu A, Cruse D, et al. A role
for the default mode network in the bases of
disorders of consciousness. Ann Neurol. 2012, 72(3):
335–343.
[8] Chen SS, Wu XH, Wang LB, et al. Disrupted
interactions between arousal and cortical awareness
networks in MCS and VS/UWS patients: evidence
from resting-state functional imaging connectivity.
Neuroscience. 2018, 382: 115–124.
[9] Cui Y, Song M, Lipnicki DM, et al. Subdivisions of
the posteromedial cortex in disorders of
consciousness. Neuroimage Clin. 2018, 20: 260–266.
[10] Naccache L. Minimally conscious state or cortically
mediated state? Brain. 2018, 141(4): 949–960.
[11] Gosseries O, Charland-Verville V, Thonnard M, et al.
Amantadine, apomorphine and zolpidem in the
treatment of disorders of consciousness. Curr Pharm

167
Des. 2014, 20(26): 4167–4184.
[12] Giacino JT, Whyte J, Bagiella E, et al.
Placebo-controlled trial of amantadine for severe
traumatic brain injury. N Engl J Med. 2012, 366(9):
819–826.
[13] Whyte J, Rajan R, Rosenbaum A, et al. Zolpidem and
restoration of consciousness. Am J Phys Med Rehabil.
2014, 93(2): 101–113.
[14] Pape TL, Rosenow JM, Steiner M, et al.
Placebo-controlled trial of familiar auditory sensory
training for acute severe traumatic brain injury: a
preliminary report. Neurorehabil Neural Repair.
2015, 29(6): 537–547.
[15] Abbate C, Trimarchi PD, Basile I, et al. Sensory
stimulation for patients with disorders of
consciousness: from stimulation to rehabilitation.
Front Hum Neurosci. 2014, 8: 616.
[16] Padua L, Cuccagna C, Pazzaglia C. Novel sensory
paradigms for neuromodulation in disorders of
consciousness in traumatic brain injury. Curr Opin
Neurol. 2019, 32(6): 844–849.
[17] Wojtecki L, Petri D, Elben S, et al. Modulation of
central thalamic oscillations during emotionalcognitive processing in chronic disorder of
consciousness. Cortex. 2014, 60: 94–102.
[18] Saleem GT, Ewen JB, Crasta JE, et al. Single-arm,
open-label, dose escalation phase I study to evaluate
the safety and feasibility of transcranial direct current
stimulation with electroencephalography biomarkers
in paediatric disorders of consciousness: a study
protocol. BMJ Open. 2019, 9(8): e029967.
[19] Liang ZH, Li JN, Xia XY, et al. Long-range temporal
correlations of patients in minimally conscious state
modulated by spinal cord stimulation. Front Physiol.
2018, 9: 1511.
[20] Bai Y, Xia XY, Kang JN, et al. Evaluating the effect
of repetitive transcranial magnetic stimulation on
disorders of consciousness by using TMS-EEG.
Front Neurosci. 2016, 10: 473.
[21] Corazzol M, Lio G, Lefevre A, et al. Restoring
consciousness with vagus nerve stimulation. Curr
Biol. 2017, 27(18): R994–R996.
[22] Rezaei Haddad A, Lythe V, Green AL. Deep brain
stimulation for recovery of consciousness in
minimally conscious patients after traumatic brain
injury: a systematic review. Neuromodulation. 2019,

Journal of Neurorestoratology

168
22(4): 373–379.
[23] Wang Y, Bai Y, Xia XY, et al. Spinal cord
stimulation modulates complexity of neural activities
in patients with disorders of consciousness. Int J
Neurosci. 2020, 130(7): 662–670.
[24] Bourdillon P, Hermann B, Sitt JD, et al.
Electromagnetic brain stimulation in patients with
disorders of consciousness. Front Neurosci. 2019, 13:
223.
[25] Hakon J, Moghiseh M, Poulsen I, et al.
Transcutaneous vagus nerve stimulation in patients
with severe traumatic brain injury: a feasibility trial.
Neuromodulation. 2020, in press, DOI 10.1111/
ner.13148.
[26] Xie H, Ji TY, Ma JY, et al. Remote programming: a
convenient and cost-effective measure of vagus nerve
stimulation for children with epilepsy. Epilepsy Res.
2020, 159: 106246.
[27] Aaronson ST, Sears P, Ruvuna F, et al. A 5-year
observational study of patients with treatmentresistant depression treated with vagus nerve
stimulation or treatment as usual: comparison of
response, remission, and suicidality. Am J Psychiatry.
2017, 174(7): 640–648.
[28] Kilgard MP. Harnessing plasticity to understand
learning and treat disease. Trends Neurosci. 2012,
35(12): 715–722.
[29] Hays SA. Enhancing rehabilitative therapies with
vagus nerve stimulation. Neurotherapeutics. 2016,
13(2): 382–394.
[30] Hachem LD, Wong SM, Ibrahim GM. The vagus
afferent network: emerging role in translational
connectomics. Neurosurg Focus. 2018, 45(3): E2.
[31] Engineer ND, Kimberley TJ, Prudente CN, et al.
Targeted vagus nerve stimulation for rehabilitation
after stroke. Front Neurosci. 2019, 13: 280.
[32] Meyers EC, Kasliwal N, Solorzano BR, et al.
Enhancing plasticity in central networks improves
motor and sensory recovery after nerve damage. Nat
Commun. 2019, 10(1): 5782.
[33] Meyers EC, Solorzano BR, James J, et al. Vagus
nerve stimulation enhances stable plasticity and
generalization of stroke recovery. Stroke. 2018, 49(3):
710–717.
[34] Childs JE, Alvarez-Dieppa AC, McIntyre CK, et al.
Vagus nerve stimulation as a tool to induce plasticity

[35]

[36]

[37]

[38]

[39]

[40]
[41]

[42]

[43]

[44]

[45]

[46]

in pathways relevant for extinction learning. J Vis
Exp. 2015(102): e53032.
Rodenkirch C, Wang Q. Rapid and transient
enhancement of thalamic information transmission
induced by vagus nerve stimulation. J Neural Eng.
2020, 17(2): 026027.
Cao JY, Lu KH, Powley TL, et al. Vagal nerve
stimulation triggers widespread responses and alters
large-scale functional connectivity in the rat brain.
PLoS One. 2017, 12(12): e0189518.
Giacino JT, Ashwal S, Childs N, et al. The minimally
conscious state: definition and diagnostic criteria.
Neurology. 2002, 58(3): 349–353.
Lozano AM. Harnessing plasticity to reset
dysfunctional neurons. N Engl J Med. 2011, 364(14):
1367–1368.
Hays SA, Rennaker RL, Kilgard MP. Targeting
plasticity with vagus nerve stimulation to treat
neurological disease. Prog Brain Res. 2013, 207:
275–299.
Bagary M. Epilepsy, consciousness and neurostimulation. Behav Neurol. 2011, 24(1): 75–81.
Malow BA, Edwards J, Marzec M, et al. Vagus nerve
stimulation reduces daytime sleepiness in epilepsy
patients. Neurology. 2001, 57(5): 879–884.
Rizzo P, Beelke M, de Carli F, et al. Chronic vagus
nerve stimulation improves alertness and reduces
rapid eye movement sleep in patients affected by
refractory epilepsy. Sleep. 2003, 26(5): 607–611.
Yu YT, Yang Y, Wang LB, et al. Transcutaneous
auricular vagus nerve stimulation in disorders of
consciousness monitored by fMRI: The first case
report. Brain Stimul. 2017, 10(2): 328–330.
Noé E, Ferri J, Colomer C, et al. Feasibility, safety
and efficacy of transauricular vagus nerve
stimulation in a cohort of patients with disorders of
consciousness. Brain Stimul. 2020, 13(2): 427–429.
Dong XY, Feng Z. Wake-promoting effects of vagus
nerve stimulation after traumatic brain injury:
upregulation of orexin-A and orexin receptor type 1
expression in the prefrontal cortex. Neural Regen Res.
2018, 13(2): 244–251.
Martínez-Vargas D, Valdés-Cruz A, MagdalenoMadrigal VM, et al. Effects of electrical stimulation
of the vagus nerve on the development of visual
Journal of Neurorestoratology

Journal of Neurorestoratology

habituation in the cat. Behav Brain Res. 2009, 205(1):
45–49.
[47] Engineer ND, Riley JR, Seale JD, et al. Reversing
pathological neural activity using targeted plasticity.

169
Nature. 2011, 470(7332): 101–104.
[48] Laureys S. The neural correlate of (un)awareness:
lessons from the vegetative state. Trends Cogn Sci.
2005, 9(12): 556–559.

Xun‐Jie Xiang, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital,
Guangxi, China. He focuses on the research and treatment of functional
neurosurgical diseases and traumatic brain diseases. E‐mail: xxjsun@163.com

Liu‐Zhong Sun, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. He
focuses on the research and treatment of functional neurosurgical diseases and
traumatic brain diseases. E‐mail: 247984643@qq.com

Cai‐Bang Xu, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. He
specializes in the interventional therapy of cerebrovascular diseases, treatment of
severe extracranial injury and nerve regulation.

Yong Xie, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. He
specializes in the disease vascular disease research, and is good at nerve
interventional therapy. E‐mail: 65045725@qq.com

170

Journal of Neurorestoratology

Ming‐Yan Pang, M.M., Neurosurgery Department of Guangxi Jiangbin Hospital. He
focuses on the research and treatment of functional neurosurgical diseases. E‐mail:
a_sol@163.com

Jiang Ran, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. He focuses
on the research and treatment of functional neurosurgical diseases and traumatic
brain diseases. E‐mail: 446220945@qq.com

Yang Hu, M.S., Neurosurgery Department of Guangxi Jiangbin Hospital. His research
focuses on cerebrovascular disease, and he is good at neurointerventional therapy.
E‐mail: 18860054785@163.com

Bang‐Xie Nong, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. His
research focuses on cerebrovascular disease, and he is good at neurointerventional
therapy. E‐mail: 286644549@qq.com

Qu Shen, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. He focuses
on the research and treatment of cerebrovascular disease, and is good at
interventional treatment of cerebrovascular disease. E‐mail:1019071818@qq.com

Journal of Neurorestoratology

Journal of Neurorestoratology

171

Hua Huang, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital. His
research focuses on cerebrovascular disease, and he is good at neurointerventional
therapy. E‐mail: 56203831@qq.com

Sheng‐Hui Huang, B.S., Neurosurgery Department of Guangxi Jiangbin Hospital.
He focus on the research and treatment of cerebrovascular disease and
craniocerebral injury. E‐mail: 974236096@qq.com

Yan‐Zhong Yu, Bachelor of Neurosurgery, Guangxi Jiangbin Hospital. He focuses on
the research and treatment of cerebrovascular disease and brain injury. E‐mail:
22739831@qq.com

